Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L-H Wong

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|March 9, 2022
Dynamic change of LSM-HCC score and enhanced liver fibrosis score to predict hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral treatment: abridged secondary publicationG L H Wong, V W S Wong
Alimentary Pharmacology & Therapeutics|September 17, 2016
Letter: which patients with hepatitis B virus-related hepatocellular carcinoma should receive nucleos(t)ide analogue therapy? Authors' replyG L-H Wong, V W-S Wong
Alimentary Pharmacology & Therapeutics|October 11, 2011
Medical therapy for primary sclerosing cholangitisG L-H Wong, V W-S Wong
Alimentary Pharmacology & Therapeutics|April 17, 2014
Commentary: coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B - authors' replyG L-H Wong, V W-S Wong
Alimentary Pharmacology & Therapeutics|November 8, 2014
When and how to use steatosis biomarkers?V W-S Wong, G L-H Wong
Alimentary Pharmacology & Therapeutics|September 13, 2012
Commentary: predicting survival in hepatocellular carcinoma patientsG L-H Wong, V W-S Wong
Alimentary Pharmacology & Therapeutics|December 17, 2011
Non-invasive algorithms for liver fibrosisZ Yu, V W-S Wong, G L-H Wong
Alimentary Pharmacology & Therapeutics|September 13, 2012
Commentary: time to update the ALT cut-off?Z Yu, G L-H Wong, V W-S Wong
Journal of Viral Hepatitis|November 18, 2014
Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis BG L-H Wong, V W-S Wong, H L-Y Chan
Alimentary Pharmacology & Therapeutics|September 18, 2014
Editorial: metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B--authors' replyJ Hsiang, G L-H Wong, H L-Y Chan, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|March 9, 2022
Dynamic change of LSM-HCC score and enhanced liver fibrosis score to predict hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral treatment: abridged secondary publicationG L H Wong, V W S Wong
Alimentary Pharmacology & Therapeutics|September 17, 2016
Letter: which patients with hepatitis B virus-related hepatocellular carcinoma should receive nucleos(t)ide analogue therapy? Authors' replyG L-H Wong, V W-S Wong
Alimentary Pharmacology & Therapeutics|October 11, 2011
Medical therapy for primary sclerosing cholangitisG L-H Wong, V W-S Wong
Alimentary Pharmacology & Therapeutics|April 17, 2014
Commentary: coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B - authors' replyG L-H Wong, V W-S Wong
Alimentary Pharmacology & Therapeutics|November 8, 2014
When and how to use steatosis biomarkers?V W-S Wong, G L-H Wong
Alimentary Pharmacology & Therapeutics|September 13, 2012
Commentary: predicting survival in hepatocellular carcinoma patientsG L-H Wong, V W-S Wong
Alimentary Pharmacology & Therapeutics|December 17, 2011
Non-invasive algorithms for liver fibrosisZ Yu, V W-S Wong, G L-H Wong
Alimentary Pharmacology & Therapeutics|September 13, 2012
Commentary: time to update the ALT cut-off?Z Yu, G L-H Wong, V W-S Wong
Journal of Viral Hepatitis|November 18, 2014
Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis BG L-H Wong, V W-S Wong, H L-Y Chan
Alimentary Pharmacology & Therapeutics|September 18, 2014
Editorial: metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B--authors' replyJ Hsiang, G L-H Wong, H L-Y Chan, et al.
Pageof 5